EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Multi‐Targeting Ligands as Prospective Therapeutics for Alzheimer's Disease, a Prevalent Neurodegenerative Disorder: Mechanistic Insights, Emerging Targets and Drug Discovery Campaigns

Amandeep Thakur, Mandeep Rana, Sakshi Vanjani, Kei-Chi Liou, Rajeev Taliyan iD, Kunal Nepali iD, Chih-Hao Yang iD

Medicinal Research Reviews · 2026-07 · 46 (4) · 1173-1229

DOI: 10.1002/med.70047 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medicinal Research Reviews, online erschienen am 19.04.2026. Verfasst von Amandeep Thakur und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan. Hauptthemen laut MEDLINE: Alzheimer Disease, Drug Discovery, Molecular Targeted Therapy, Neurodegenerative Diseases. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 388 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, Taiwan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) is a debilitating neurodegenerative condition characterized by progressive cognitive impairment, memory deterioration, and neuronal dysfunction. Its complex pathophysiology involves multiple interlinked processes, including amyloid‐β (Aβ) aggregation, tau hyperphosphorylation, oxidative stress, neuroinflammation, synaptic dysfunction, and cholinergic deficits. Current FDA‐approved therapies provide only symptomatic relief and fail to halt disease progression, highlighting the urgent need for more effective treatment strategies. This review provides a comprehensive overview of the pathological mechanisms underlying AD and the emerging therapeutic targets for the design of tractable anti‐AD scaffolds, namely, acetylcholinesterase, beta‐site amyloid precursor protein cleaving enzyme 1 (BACE1), glycogen synthase kinase‐3β (GSK3β), dual‐specificity tyrosine phosphorylation‐regulated kinase 1A (DYRK1A), histone deacetylases (HDACs), and soluble epoxide hydrolase (sEH). Emphasis is placed on the paradigm shift from single‐target therapies to multitarget‐directed ligands (MTDLs), which are increasingly recognized as promising tools to tackle AD's multifactorial pathology. We also discuss recent advances in medicinal chemistry and structure‐guided drug discovery campaigns aimed at developing pharmacologically optimized, BBB‐penetrant MTDLs. By consolidating mechanistic insights with therapeutic innovation, this review aims to facilitate the development of next‐generation therapeutics with enhanced efficacy and disease‐modifying potential in AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseDrug DiscoveryMolecular Targeted TherapyNeurodegenerative DiseasesHumansLigandsAnimals

Stichwörter der Autor:innen

Alzheimer'sAlzheimer's pathologyAlzheimer's targetsmultitargeting ligandsneurodegeneration

Substanzen

Ligands

Autor:innen und Institutionen

  • School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan.
  • Molecular Medicine, University of South Florida, Tampa, Florida, USA.
  • Department of Pharmacy, Birla Institute of Technology & Science, Pilani, Rajasthan, India.
  • Ph.D. Program in Drug Discovery and Development Industry, College of Pharmacy, Taipei Medical University, Taipei, Taiwan.
  • Department of Pharmacology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
  • Research Center for Neuroscience, Taipei Medical University, Taipei, Taiwan.

ORCID-Profile: Rajeev Taliyan, Kunal Nepali, Chih-Hao Yang

Förderung

  • National Science and Technology Council, Taiwan

Zitieren

APA

Thakur, A., Rana, M., Vanjani, S., Liou, K. C., Taliyan, R., Nepali, K., & Yang, C. H. (2026). Multi‐Targeting Ligands as Prospective Therapeutics for Alzheimer's Disease, a Prevalent Neurodegenerative Disorder: Mechanistic Insights, Emerging Targets and Drug Discovery Campaigns. Medicinal Research Reviews, 46(4), 1173-1229. https://doi.org/10.1002/med.70047

Vancouver

Thakur A, Rana M, Vanjani S, Liou KC, Taliyan R, Nepali K, et al. Multi‐Targeting Ligands as Prospective Therapeutics for Alzheimer's Disease, a Prevalent Neurodegenerative Disorder: Mechanistic Insights, Emerging Targets and Drug Discovery Campaigns. Medicinal Research Reviews. 2026;46(4):1173-1229. doi:10.1002/med.70047

BibTeX
@article{Thakur2026,
  author = {Thakur, Amandeep and Rana, Mandeep and Vanjani, Sakshi and Liou, Kei-Chi and Taliyan, Rajeev and Nepali, Kunal and Yang, Chih-Hao},
  title = {Multi‐Targeting Ligands as Prospective Therapeutics for Alzheimer's Disease, a Prevalent Neurodegenerative Disorder: Mechanistic Insights, Emerging Targets and Drug Discovery Campaigns},
  journal = {Medicinal Research Reviews},
  year = {2026},
  volume = {46},
  number = {4},
  pages = {1173--1229},
  doi = {10.1002/med.70047}
}
Kostenlos starten →